Advertisement
LABX vs SSO
Which ETF would AI Choose? Tradr 2X Long ALAB Daily ETF (LABX) vs. ProShares Ultra S&P500 (SSO)
Key Takeaways
- Tradr 2X Long ALAB Daily ETF (LABX) provides 2x daily leveraged exposure to a single semiconductor stock, Astera Labs Inc. (ALAB), while ProShares Ultra S&P500 (SSO) delivers 2x daily exposure to the broad S&P 500 index.
- LABX employs total return swaps and options for its concentrated strategy with an expense ratio of 1.30%, whereas SSO uses derivatives for diversified large-cap coverage at a lower expense ratio of 0.84%.
- Both ETFs reset daily and are designed for short-term trading rather than long-term holding, leading to potential compounding effects and volatility decay over extended periods.
- LABX offers high-risk thematic exposure to the semiconductor sector with minimal holdings, while SSO provides broad market diversification across multiple sectors including technology, financial services, and healthcare.
- Structural differences position LABX as a tactical tool for targeted volatility plays and SSO as a leveraged vehicle for overall U.S. equity market participation.
- Cost efficiency and diversification favor SSO in most market environments, though LABX may appeal to investors seeking amplified single-stock semiconductor momentum.
Introduction
Tradr 2X Long ALAB Daily ETF (LABX) and ProShares Ultra S&P500 (SSO) represent distinct leveraged strategies that appeal to investors seeking amplified daily returns. They do not compete directly but offer alternative approaches to leveraged equity exposure: one concentrated on a single semiconductor name and the other on a broad large-cap benchmark. In the current environment of sector rotation and interest-rate sensitivity, these ETFs illustrate trade-offs between thematic precision and market-wide participation for short-term tactical allocation.
Tradr 2X Long ALAB Daily ETF (LABX) Overview
The Tradr 2X Long ALAB Daily ETF (LABX) seeks daily investment results, before fees and expenses, that correspond to two times (200%) the daily performance of Astera Labs Inc. (ALAB). Launched in August 2025, it is an actively managed leveraged product that primarily uses total return swap agreements, with potential use of FLEX options or direct holdings when swaps are unavailable. The fund maintains very few holdings, typically centered on instruments tied to ALAB, a semiconductor company. Its expense ratio stands at 1.30%. As a single-asset leveraged vehicle, LABX exhibits extreme concentration risk and requires daily monitoring due to its daily reset mechanism.
ProShares Ultra S&P500 (SSO) Overview
The ProShares Ultra S&P500 (SSO) seeks daily investment results, before fees and expenses, that correspond to two times (200%) the daily performance of the S&P 500 index. Established in 2006, it is a passive leveraged ETF that achieves its objective through a combination of swaps, futures, and other derivatives backed by cash equivalents. The fund provides exposure to approximately 500 large- and mid-cap U.S. companies across all major sectors. Its net expense ratio is 0.84%. With broad diversification and high liquidity, SSO serves as a core leveraged equity tool for market participants seeking amplified broad-market beta.
Industry and Thematic Backdrop
The U.S. equity market continues to navigate sector-specific momentum in technology and semiconductors alongside broader economic factors such as monetary policy and corporate earnings growth. Semiconductor demand tied to artificial intelligence and data infrastructure provides thematic support for concentrated plays, while the S&P 500 reflects aggregate performance across technology, financial services, healthcare, and consumer sectors. Capital flows into leveraged products remain sensitive to volatility levels and macroeconomic signals, with regulatory scrutiny on leveraged and inverse products emphasizing their short-term nature.
Performance and Positioning Comparison
In recent market cycles, the concentrated semiconductor focus of LABX has produced amplified moves relative to the broader market during periods of tech outperformance or sector rotation. SSO has delivered leveraged participation aligned with overall S&P 500 trends, benefiting from diversification that moderates single-sector swings. Both funds experience heightened volatility due to daily resets, with LABX showing greater sensitivity to ALAB-specific developments and SSO reflecting market-wide shifts in earnings cycles, interest-rate expectations, and capital allocation trends. Relative positioning highlights LABX’s higher risk-reward profile versus SSO’s more balanced leveraged market exposure.
AI Screener
Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps identify trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. Visit the AI Screener to explore current opportunities.
Tickeron AI Verdict
Based on structural characteristics, Tickeron’s AI would currently assign a higher probability of favorability to ProShares Ultra S&P500 (SSO). Its lower expense ratio, broad diversification across the S&P 500, and established liquidity profile provide a more resilient framework for leveraged exposure compared with the single-stock concentration and higher costs of LABX. This assessment rests on observable factors including cost efficiency, risk dispersion, and consistency of the underlying benchmark.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LABX is a Hold and SSO is a Hold.
Momentum Indicator for LABX turns negative, indicating new downward trend
LABX saw its Momentum Indicator move below the 0 level on October 08, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 20 similar instances where the indicator turned negative. In 20 of the 20 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Moving Average Convergence Divergence Histogram (MACD) for LABX turned negative on October 09, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 11 similar instances when the indicator turned negative. In 10 of the 11 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
LABX moved below its 50-day moving average on October 12, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for LABX crossed bearishly below the 50-day moving average on October 20, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 3 of 3 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where LABX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for LABX entered a downward trend on November 04, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
Following a +30.16% 3-day Advance, the price is estimated to grow further. Considering data from situations where LABX advanced for three days, in 75 of 78 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.
LABX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
SSO sees its Stochastic Oscillator ascending out of oversold territory
On November 04, 2026, the Stochastic Oscillator for SSO moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 51 instances where the indicator left the oversold zone. In 48 of the 51 cases the stock moved higher in the following days. This puts the odds of a move higher at over 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
Following a +3.88% 3-day Advance, the price is estimated to grow further. Considering data from situations where SSO advanced for three days, in 314 of 351 cases, the price rose further within the following month. The odds of a continued upward trend are 89%.
SSO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 29, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SSO as a result. In 61 of 75 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 81%.
The Moving Average Convergence Divergence Histogram (MACD) for SSO turned negative on October 15, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 53 similar instances when the indicator turned negative. In 47 of the 53 cases the stock turned lower in the days that followed. This puts the odds of success at 89%.
SSO moved below its 50-day moving average on October 30, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for SSO crossed bearishly below the 50-day moving average on October 26, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 86%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SSO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
The Aroon Indicator for SSO entered a downward trend on November 04, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
| LABX | SSO | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 90% | N/A |
| Stochastic ODDS (%) | 2 days ago 90% | 2 days ago 90% |
| Momentum ODDS (%) | 2 days ago 90% | 2 days ago 81% |
| MACD ODDS (%) | 2 days ago 90% | 2 days ago 89% |
| TrendWeek ODDS (%) | 2 days ago 90% | 2 days ago 85% |
| TrendMonth ODDS (%) | 2 days ago 90% | 2 days ago 88% |
| Advances ODDS (%) | 9 days ago 90% | 2 days ago 89% |
| Declines ODDS (%) | 4 days ago 90% | 4 days ago 84% |
| BollingerBands ODDS (%) | 2 days ago 90% | 2 days ago 90% |
| Aroon ODDS (%) | 2 days ago 90% | 2 days ago 90% |
Advertisement
LABX and
Correlation & Price change
A.I.dvisor tells us that LABX and ALAB have been poorly correlated (+4% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LABX and ALAB's prices will move in lockstep.
| Ticker / NAME | Correlation To LABX | 1D Price Change % | ||
|---|---|---|---|---|
| LABX | 100% | -8.56% | ||
| ALAB - LABX | 4% Poorly correlated | -4.43% |